Browsing: Business And Money

At Apple’s much-anticipated “Glowtime” event, the spotlight shone brightly on the tech giant’s AI platform, Apple Intelligence. However, nestled among…

After a 13-day standoff, Disney and DirecTV have reached an agreement to restore 16 Disney-owned networks, including ABC and ESPN,…

Adobe Inc. shares saw their sharpest decline in six months after the company issued an underwhelming financial outlook, causing frustration…

The U.S. Department of Justice and several state attorneys have filed a significant antitrust lawsuit against Google, accusing the company…

Tiger Global is preparing to take part in OpenAI’s highly anticipated new funding round, which would value the artificial intelligence…

General Mills announced on Thursday that it plans to sell its North American yogurt business to French dairy giants Groupe…

Norfolk Southern, one of America’s leading freight carriers, announced Thursday that it has fired its Chief Executive Officer, Alan Shaw,…

Boeing workers are voting Thursday on a new labor contract that could determine the company’s immediate future. The outcome of…

Slightly more Americans filed for unemployment benefits last week, with claims rising by 2,000 to 230,000 for the week ending…

Social Security recipients have been receiving significant cost-of-living adjustments (COLAs) over the past few years, thanks to record-high inflation. However,…

The U.S. inflation rate rose 0.2% in August, matching both July’s increase and economists’ predictions. On a core basis, which…

After more than a century of being synonymous with its iconic red-and-white soup cans, Campbell’s Soup Company is officially dropping…

In the industrial heart of South Memphis, a new factory owned by Elon Musk is rapidly taking shape, with the…

As if it was Trump’s fault, media is painting the story as follows… The stock price of Trump Media plummeted…

U.S. bank stocks took a hit on Wednesday, continuing their downward trend as concerns mount over the potential impact of…

On Monday, AstraZeneca Plc (NASDAQ: AZN) revealed detailed results from its Phase 3 TROPION-Lung01 trial comparing datopotamab deruxtecan (Dato-DXd) to…